Treatment of SARS-CoV-2 in paediatrics : what is the evidence to date?
Revue Medicale Suisse
; 17(726):344-348, 2021.
Article
in French
| EMBASE | ID: covidwho-1885059
ABSTRACT
Although SARS-CoV-2 infects individuals of all ages, children show less severe symptoms. Nevertheless, the very rare COVID-19 severe cases in paediatrics require our full attention. Much research has been conducted and is still ongoing on effective treatments. On the antiviral front, no molecule has been proven effective yet and the results of several studies on the benefit of monoclonal antibodies and convalescent plasma are pending. On the side of immunomodulators, the benefit of steroids has been demonstrated for patients severely ill. Other molecules are being investigated. However, all these studies focused on adults and paediatric data are warranted.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
French
Journal:
Revue Medicale Suisse
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS